Home

deras Förstörd Skåpbil lineage 2 level gap 19 pollinerare Akrobatik Öde

REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19 |  NEJM
REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19 | NEJM

Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large  integrated health system in the USA: a retrospective cohort study - The  Lancet
Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study - The Lancet

COVID-19-related hyperglycemia is associated with infection of hepatocytes  and stimulation of gluconeogenesis | PNAS
COVID-19-related hyperglycemia is associated with infection of hepatocytes and stimulation of gluconeogenesis | PNAS

Frontiers | Role of the Microbiome in the Pathogenesis of COVID-19
Frontiers | Role of the Microbiome in the Pathogenesis of COVID-19

Difference in mortality among individuals admitted to hospital with COVID-19  during the first and second waves in South Africa: a cohort study - The  Lancet Global Health
Difference in mortality among individuals admitted to hospital with COVID-19 during the first and second waves in South Africa: a cohort study - The Lancet Global Health

Frontiers | Failure of ALL recognition by CAR T cells: a review of CD 19-negative  relapses after anti-CD 19 CAR-T treatment in B-ALL
Frontiers | Failure of ALL recognition by CAR T cells: a review of CD 19-negative relapses after anti-CD 19 CAR-T treatment in B-ALL

Antibody response against SARS-CoV-2 variants of concern in children  infected with pre-Omicron variants: An observational cohort study -  eBioMedicine
Antibody response against SARS-CoV-2 variants of concern in children infected with pre-Omicron variants: An observational cohort study - eBioMedicine

Structural and functional properties of SARS-CoV-2 spike protein: potential  antivirus drug development for COVID-19 | Acta Pharmacologica Sinica
Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19 | Acta Pharmacologica Sinica

Characteristics of SARS-CoV-2 and COVID-19 | Nature Reviews Microbiology
Characteristics of SARS-CoV-2 and COVID-19 | Nature Reviews Microbiology

Considerations around the SARS-CoV-2 Spike Protein with Particular  Attention to COVID-19 Brain Infection and Neurological Symptoms | ACS  Chemical Neuroscience
Considerations around the SARS-CoV-2 Spike Protein with Particular Attention to COVID-19 Brain Infection and Neurological Symptoms | ACS Chemical Neuroscience

Clinical and Laboratory Diagnosis of SARS-CoV-2, the Virus Causing COVID-19  | ACS Infectious Diseases
Clinical and Laboratory Diagnosis of SARS-CoV-2, the Virus Causing COVID-19 | ACS Infectious Diseases

The sex and gender dimensions of COVID-19: A narrative review of the  potential underlying factors - ScienceDirect
The sex and gender dimensions of COVID-19: A narrative review of the potential underlying factors - ScienceDirect

Mucosal immune response in BNT162b2 COVID-19 vaccine recipients -  eBioMedicine
Mucosal immune response in BNT162b2 COVID-19 vaccine recipients - eBioMedicine

Temporal maturation of neutralizing antibodies in COVID-19 convalescent  individuals improves potency and breadth to circulating SARS-CoV-2 variants  - ScienceDirect
Temporal maturation of neutralizing antibodies in COVID-19 convalescent individuals improves potency and breadth to circulating SARS-CoV-2 variants - ScienceDirect

Systems biological assessment of immunity to mild versus severe COVID-19  infection in humans | Science
Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans | Science

Emergence of SARS-CoV-2 B.1.1.7 Lineage — United States, December 29,  2020–January 12, 2021 | MMWR
Emergence of SARS-CoV-2 B.1.1.7 Lineage — United States, December 29, 2020–January 12, 2021 | MMWR

A comprehensive SARS-CoV-2 and COVID-19 review, Part 1: Intracellular  overdrive for SARS-CoV-2 infection | European Journal of Human Genetics
A comprehensive SARS-CoV-2 and COVID-19 review, Part 1: Intracellular overdrive for SARS-CoV-2 infection | European Journal of Human Genetics

T cell responses in patients with COVID-19 | Nature Reviews Immunology
T cell responses in patients with COVID-19 | Nature Reviews Immunology

Rapid evaluation of COVID-19 vaccine effectiveness against symptomatic  infection with SARS-CoV-2 variants by analysis of genetic distance | Nature  Medicine
Rapid evaluation of COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 variants by analysis of genetic distance | Nature Medicine

Frontiers | COVID-19 Lung Pathogenesis in SARS-CoV-2 Autopsy Cases
Frontiers | COVID-19 Lung Pathogenesis in SARS-CoV-2 Autopsy Cases

Prediction of hospital-onset COVID-19 infections using dynamic networks of  patient contact: an international retrospective cohort study - The Lancet  Digital Health
Prediction of hospital-onset COVID-19 infections using dynamic networks of patient contact: an international retrospective cohort study - The Lancet Digital Health

COVID-19 immune features revealed by a large-scale single-cell  transcriptome atlas - ScienceDirect
COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas - ScienceDirect

The Lancet Commission on lessons for the future from the COVID-19 pandemic  - The Lancet
The Lancet Commission on lessons for the future from the COVID-19 pandemic - The Lancet

Cells | Free Full-Text | Characterization and Biomarker Analyses of  Post-COVID-19 Complications and Neurological Manifestations
Cells | Free Full-Text | Characterization and Biomarker Analyses of Post-COVID-19 Complications and Neurological Manifestations

Age groups that sustain resurging COVID-19 epidemics in the United States |  Science
Age groups that sustain resurging COVID-19 epidemics in the United States | Science

SARS-CoV-2-specific antibody and T-cell responses 1 year after infection in  people recovered from COVID-19: a longitudinal cohort study - The Lancet  Microbe
SARS-CoV-2-specific antibody and T-cell responses 1 year after infection in people recovered from COVID-19: a longitudinal cohort study - The Lancet Microbe